Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 6;22(5):749.
doi: 10.3390/molecules22050749.

New Applications of Heparin and Other Glycosaminoglycans

Marcelo Lima  1   2 , Timothy Rudd  3   4 , Edwin Yates  5   6
Affiliations
Review

New Applications of Heparin and Other Glycosaminoglycans

Marcelo Lima et al. Molecules. .

Abstract

Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a century. Its introduction reduced clotting risks substantially and subsequent developments, including the introduction of low-molecular-weight heparin, made possible many major surgical interventions that today make heparin an indispensable drug. There has been a recent burgeoning of interest in heparin and related glycosaminoglycan (GAG) polysaccharides, such as chondroitin sulfates, heparan sulfate, and hyaluronate, as potential agents in various applications. This ability arises mainly from the ability of GAGs to interact with, and alter the activity of, a wide range of proteins. Here, we review new developments (since 2010) in the application of heparin and related GAGs across diverse fields ranging from thrombosis and neurodegenerative disorders to microbiology and biotechnology.

Keywords: chondroitin sulfate; glycosaminoglycans; heparin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Barrowcliffe T.W. History of heparin. Handb. Exp. Pharmacol. 2012;207:3–22. - PubMed
    1. Nader H.B., McDuffie N.M., Dietrich C.P. Heparin fractionation by electrofocusing: presence of 21 components of different molecular weights. Biochem. Biophys. Res. Commun. 1974;57:488–493. doi: 10.1016/0006-291X(74)90958-9. - DOI - PubMed
    1. McDuffie N.M., Dietrich C.P., Nader H.B. Electrofocusing of heparin: Fractionation of heparin into 21 components distinguishable from other acidic mucopolysaccharides. Biopolymers. 1975;14:1473–1486. doi: 10.1002/bip.1975.360140713. - DOI - PubMed
    1. Dietrich C.P., Nader H.B., Mcduffie N.N. Electrofocusing of heparin: Presence of 21 monomeric and dimeric molecular species in heparin preparations. An. Acad. Bras. Cienc. 1975;47:301–309. - PubMed
    1. Perlin A.S., Mackie D.M., Dietrich C.P. Evidence for a (1→4)-linked 4-O-(α-l-idopyranosyluronic acid 2-sulfate)-(2-deoxy-2-sulfoamino-d-glucopyranosyl 6-sulfate) sequence in heparin. Carbohydr. Res. 1971;18:185–194. doi: 10.1016/S0008-6215(00)80341-9. - DOI - PubMed

MeSH terms

LinkOut - more resources